G Birgegard, M Bjorkholm, J Kutti, G Larfars, E Lofvenberg, B Markevarn, M Merup, J Palmblad, N Mauritzson, J Westin, J Samuelsson. Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders. Haematologica 2004;89(5):520-527; https://doi.org/10.3324/%x.